1. Home
  2. |Insights
  3. |AAI International Antitrust Roundtable: Critical Issues in Global Antitrust - Comity, Intellectual Property, and Due Process

AAI International Antitrust Roundtable: Critical Issues in Global Antitrust - Comity, Intellectual Property, and Due Process

Event | 02.08.17, 4:00 AM EST - 12:00 PM EST

Address

National Press Club
529 14th St NW, Washington, D.C.

As competition enforcement agencies in the U.S. and abroad revise their international and/or intellectual property (IP) guidelines, and a new administration takes over in Washington, it is an opportune time to survey a number of issues and controversies. These include the extraterritorial and overlapping application of U.S. and foreign competition law, as well as some of the critical IP/competition issues facing antitrust authorities around the globe. In the process, the Roundtable will take stock of growing concerns over foreign jurisdictions’ due process standards (or lack thereof). These not only raise independent “good governance” issues but also may influence the debate over comity and substantive international antitrust and IP standards. 

The Roundtable will consist of an introductory review of key developments in the year, three panels, and a keynote luncheon address. Each panel is followed by a moderated discussion among the panelists and the audience. 


Antitrust Group Senior Counsel Lisa Kimmel is a panelist. Her topic: "Limitations on Patent Enforcement - A Comparative International Assessment."


For more information, please visit these areas: Litigation and Trial

Participants

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.